51. The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study

Autor:	Zeineddine, Maya 1, 2, Al-Roughani, Raed 3, Ahmed, Samar Farouk 4, Al-Mahdawi, Akram 5, Khoury, Samia 6, El-Ayoubi, Nabil 6, Inshasi, Jihad 7, Al-Khabouri, Jaber 8, Al-Asmi, Abdullah 9, Gouider, Riadh 10, Aljarallah, Salman 11, Alkhawajah, Nuha 11, Malik, Yaser Al 12, 13, Abulaban, Ahmad 12, 13, Makkawi, Seraj 12, 13, 14, Khojah, Osama 12, 13, 14, El-Hajj, Taghrid 15, Massouh, Joelle 16, AlSalamat, Husam 17, Dimassi, Hani 2, Al-Hajje, Amal 18, 19, Salameh, Pascale 18, 19, 20, 21, Boumediene, Farid 1, Yamout, Bassem 16
Zdroj:	In Multiple Sclerosis and Related Disorders December 2024 92
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect